Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Low-dose Aspirin in Gastrointestinal Cancer Prevention -United Kingdom ("ENgAGE - UK"): A Cohort Study on the Risk of Gastric and Oesophageal Cancer Among New Users of Low-dose Aspirin Using the THIN Database in the UK

NCT03743883 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03743883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03743883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Low-dose Aspirin in Gastrointestinal Cancer Prevention -United Kingdom ("ENgAGE - UK"): A Cohort Study on the Risk of Gastric and Oesophageal Cancer Among New Users of Low-dose Aspirin Using the THIN Database in the UK
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 30, 2018
Completion date
May 31, 2019
Enrollment
99,999 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of oesophagus cancer and stomach cancer